Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical TrialAdrian Boswood, Philip Watson, María Josefa Fernández del Palacio et al.|Journal of Veterinary Internal Medicine|2016Cited by 318
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL StudyPhilip R. Fox, Marie de Swarte, Michele Borgarelli et al.|Journal of Veterinary Internal Medicine|2018Cited by 152
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC StudyAdrian Boswood, Philip Watson, María Josefa Fernández del Palacio et al.|Journal of Veterinary Internal Medicine|2017Cited by 78
Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart diseaseMark A. Oyama, Faı̈ez Zannad, D. David Sisson et al.|Journal of the American Veterinary Medical Association|2013Cited by 59